Moderate to Severe Rheumatoid Arthritis
Also known as: Moderate-to-severe Rheumatoid Arthritis
Drug | Drug Name | Drug Description |
---|---|---|
DB01281 | Abatacept | A disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease. |
DB00051 | Adalimumab | A monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis. |
DB00328 | Indomethacin | A nonsteroidal anti-inflammatory (NSAID) used for symptomatic management of chronic musculoskeletal pain conditions and to induce closure of a hemodynamically significant patent ductus arteriosus in premature infants. |
DB06273 | Tocilizumab | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00051 | Adalimumab | 3 | Completed | 1 |
DB00005 | Etanercept | 4 | Terminated | 1 |
DB00563 | Methotrexate | 4 | Terminated | 1 |